Cargando…

Markov Networks of Collateral Resistance: National Antimicrobial Resistance Monitoring System Surveillance Results from Escherichia coli Isolates, 2004-2012

Surveillance of antimicrobial resistance (AMR) is an important component of public health. Antimicrobial drug use generates selective pressure that may lead to resistance against to the administered drug, and may also select for collateral resistances to other drugs. Analysis of AMR surveillance dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Love, William J., Zawack, Kelson A., Booth, James G., Grӧhn, Yrjo T., Lanzas, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112851/
https://www.ncbi.nlm.nih.gov/pubmed/27851767
http://dx.doi.org/10.1371/journal.pcbi.1005160
_version_ 1782468088048910336
author Love, William J.
Zawack, Kelson A.
Booth, James G.
Grӧhn, Yrjo T.
Lanzas, Cristina
author_facet Love, William J.
Zawack, Kelson A.
Booth, James G.
Grӧhn, Yrjo T.
Lanzas, Cristina
author_sort Love, William J.
collection PubMed
description Surveillance of antimicrobial resistance (AMR) is an important component of public health. Antimicrobial drug use generates selective pressure that may lead to resistance against to the administered drug, and may also select for collateral resistances to other drugs. Analysis of AMR surveillance data has focused on resistance to individual drugs but joint distributions of resistance in bacterial populations are infrequently analyzed and reported. New methods are needed to characterize and communicate joint resistance distributions. Markov networks are a class of graphical models that define connections, or edges, between pairs of variables with non-zero partial correlations and are used here to describe AMR resistance relationships. The graphical least absolute shrinkage and selection operator is used to estimate sparse Markov networks from AMR surveillance data. The method is demonstrated using a subset of Escherichia coli isolates collected by the National Antimicrobial Resistance Monitoring System between 2004 and 2012 which included AMR results for 16 drugs from 14418 isolates. Of the 119 possible unique edges, 33 unique edges were identified at least once during the study period and graphical density ranged from 16.2% to 24.8%. Two frequent dense subgraphs were noted, one containing the five β-lactam drugs and the other containing both sulfonamides, three aminoglycosides, and tetracycline. Density did not appear to change over time (p = 0.71). Unweighted modularity did not appear to change over time (p = 0.18), but a significant decreasing trend was noted in the modularity of the weighted networks (p < 0.005) indicating relationships between drugs of different classes tended to increase in strength and frequency over time compared to relationships between drugs of the same class. The current method provides a novel method to study the joint resistance distribution, but additional work is required to unite the underlying biological and genetic characteristics of the isolates with the current results derived from phenotypic data.
format Online
Article
Text
id pubmed-5112851
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-51128512016-12-08 Markov Networks of Collateral Resistance: National Antimicrobial Resistance Monitoring System Surveillance Results from Escherichia coli Isolates, 2004-2012 Love, William J. Zawack, Kelson A. Booth, James G. Grӧhn, Yrjo T. Lanzas, Cristina PLoS Comput Biol Research Article Surveillance of antimicrobial resistance (AMR) is an important component of public health. Antimicrobial drug use generates selective pressure that may lead to resistance against to the administered drug, and may also select for collateral resistances to other drugs. Analysis of AMR surveillance data has focused on resistance to individual drugs but joint distributions of resistance in bacterial populations are infrequently analyzed and reported. New methods are needed to characterize and communicate joint resistance distributions. Markov networks are a class of graphical models that define connections, or edges, between pairs of variables with non-zero partial correlations and are used here to describe AMR resistance relationships. The graphical least absolute shrinkage and selection operator is used to estimate sparse Markov networks from AMR surveillance data. The method is demonstrated using a subset of Escherichia coli isolates collected by the National Antimicrobial Resistance Monitoring System between 2004 and 2012 which included AMR results for 16 drugs from 14418 isolates. Of the 119 possible unique edges, 33 unique edges were identified at least once during the study period and graphical density ranged from 16.2% to 24.8%. Two frequent dense subgraphs were noted, one containing the five β-lactam drugs and the other containing both sulfonamides, three aminoglycosides, and tetracycline. Density did not appear to change over time (p = 0.71). Unweighted modularity did not appear to change over time (p = 0.18), but a significant decreasing trend was noted in the modularity of the weighted networks (p < 0.005) indicating relationships between drugs of different classes tended to increase in strength and frequency over time compared to relationships between drugs of the same class. The current method provides a novel method to study the joint resistance distribution, but additional work is required to unite the underlying biological and genetic characteristics of the isolates with the current results derived from phenotypic data. Public Library of Science 2016-11-16 /pmc/articles/PMC5112851/ /pubmed/27851767 http://dx.doi.org/10.1371/journal.pcbi.1005160 Text en © 2016 Love et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Love, William J.
Zawack, Kelson A.
Booth, James G.
Grӧhn, Yrjo T.
Lanzas, Cristina
Markov Networks of Collateral Resistance: National Antimicrobial Resistance Monitoring System Surveillance Results from Escherichia coli Isolates, 2004-2012
title Markov Networks of Collateral Resistance: National Antimicrobial Resistance Monitoring System Surveillance Results from Escherichia coli Isolates, 2004-2012
title_full Markov Networks of Collateral Resistance: National Antimicrobial Resistance Monitoring System Surveillance Results from Escherichia coli Isolates, 2004-2012
title_fullStr Markov Networks of Collateral Resistance: National Antimicrobial Resistance Monitoring System Surveillance Results from Escherichia coli Isolates, 2004-2012
title_full_unstemmed Markov Networks of Collateral Resistance: National Antimicrobial Resistance Monitoring System Surveillance Results from Escherichia coli Isolates, 2004-2012
title_short Markov Networks of Collateral Resistance: National Antimicrobial Resistance Monitoring System Surveillance Results from Escherichia coli Isolates, 2004-2012
title_sort markov networks of collateral resistance: national antimicrobial resistance monitoring system surveillance results from escherichia coli isolates, 2004-2012
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112851/
https://www.ncbi.nlm.nih.gov/pubmed/27851767
http://dx.doi.org/10.1371/journal.pcbi.1005160
work_keys_str_mv AT lovewilliamj markovnetworksofcollateralresistancenationalantimicrobialresistancemonitoringsystemsurveillanceresultsfromescherichiacoliisolates20042012
AT zawackkelsona markovnetworksofcollateralresistancenationalantimicrobialresistancemonitoringsystemsurveillanceresultsfromescherichiacoliisolates20042012
AT boothjamesg markovnetworksofcollateralresistancenationalantimicrobialresistancemonitoringsystemsurveillanceresultsfromescherichiacoliisolates20042012
AT gröhnyrjot markovnetworksofcollateralresistancenationalantimicrobialresistancemonitoringsystemsurveillanceresultsfromescherichiacoliisolates20042012
AT lanzascristina markovnetworksofcollateralresistancenationalantimicrobialresistancemonitoringsystemsurveillanceresultsfromescherichiacoliisolates20042012